Chola MS Targets OD Loss Ratio Below 80% in Two Quarters

Cholamandalam Financial Holdings Limited — Q1 FY2027 Earnings Call (quarter ended June 30, 2026)

1. Overall Tone of Management: Neutral (with pockets of cautious optimism)

• Management repeatedly acknowledges “highly competitive” conditions and that the “growth was below our expectations”.
• However, they show confidence in execution via “corrective measures” and explicitly guide toward improvement (e.g., OD loss ratio targets), while also emphasizing uncertainty on regulatory/judicial items.

2. Key Themes from Management Commentary

• Insurance focus (Chola MS): Call is predominantly about general insurance performance and corrective actions.
• Industry pressure:
• Fire and health under pressure due to pricing competition and claims inflation.
• Motor OD/TP remain challenging; combined ratio deterioration is industry-wide.
• Chola MS performance vs expectations:
• GDPI: Rs. 1,860 cr (+2.6% YoY)
• GWP: Rs. 2,130 cr (+6.7% YoY) but “below our expectations” due to lower volumes in commercial lines and motor and competitive pricing in fire and health.
• Motor OD is the central problem:
• Management states OD loss ratio is not acceptable and is a “journey” taking “a couple of quarters” to show meaningful results.
• They attribute deterioration to claims inflation and reserving/claims severity dynamics.
• Corrective actions underway (execution theme):
• Portfolio optimization, targeted pricing, NCB sourcing, tighter underwriting controls, strengthened claims management.
• For health: product redesign, pricing revisions, migration of select group portfolios to retail, SME expansion.
• Fire/commercial lines moderation expected:
• After NATCAT events in June, they expect greater pricing discipline in property insurance.
• Reinsurance capacity / inward reinsurance:
• They highlight better reinsurance treaties secured earlier and explain inward reinsurance as part of risk management and treaty utilization.
• Regulatory & accounting transitions as uncertainty:
• Ind AS / RBC / DPDP readiness mentioned.
• IFRS impact: they explicitly refuse to quantify yet due to ongoing assessment.
• Judicial uncertainty (Supreme Court homemaker case):
• They did not provision during the quarter; will monitor review petition outcome.

3. Q&A Analysis

Theme A: Motor TP/OD loss ratio drivers & reserving (incl. Supreme Court impact)

• Core questions:
• Whether motor TP claims ratio increase is due to Supreme Court homemaker ruling provisioning or “business as usual”.
• Whether OD loss ratio deterioration (to 80%+) is sustainable given 4+4 regulations and discounting risk.
• Timing/path to bring OD loss ratio back toward historical levels.
• Management response:
• No additional provision taken in the quarter for Supreme Court judgment:
  • “We have not taken any provision during the quarter in relation to the Supreme Court judgment.”
• OD loss ratio not acceptable; corrective measures will take time:
  • “This is a journey, and it will likely take a couple of quarters…”
• They set explicit OD targets:
  • Immediate objective: “bring the OD loss ratio down… begins with a ‘7’, ideally in the high-70s”
  • Then: “progressively move towards the mid-70s range over time.”
• They argue OD deterioration is not “pure reserve strengthening” but claims inflation assumptions and evolving experience.
• Evasive/partial/strong points:
• Strong: clear OD numeric targets and timeframe (“couple of quarters” for meaningful results).
• Partial: limited quantification of how much of OD/TP movement is new book vs reserve beyond “largely driven by claims inflation assumptions.”

Theme B: Health strategy—why retail health declined vs industry growth

• Core questions:
• Why health (group vs retail) declined while industry retail health is robust.
• Whether strategy is being revisited and what’s driving degrowth.
• Management response:
• Health is “building capabilities from the ground up.”
• Group health:
  • “virtually no gross-subsidy business left” → explains degrowth.
  • Standalone group health: growth moderate due to profitability-first approach.
• Retail health: requires patience; they are evaluating expansion via bancassurance partners and select retail/aggregator broking.
• They attribute decline largely to pricing corrections in PSU bank platform business and migration to retail where economics are better.
• Evasive/partial/strong points:
• Mostly direct and structured explanation; however, they avoid giving a clear quantified retail health recovery timeline.

Theme C: Commercial lines growth, reinsurance accepted growth, and pricing discipline

• Core questions:
• Whether reinsurance accepted growth is sustainable and where it sits (commercial vs health vs crop).
• Whether CAT events and reinsurance treaty structure will drive pricing discipline next year.
• Role of GIFT City in soft reinsurance market and whether softness could persist.
• Management response:
• Inward reinsurance has two elements:
  1) commercial lines strategy (manage net retention / treaty utilization)
  2) selective participation in group health
• CAT discipline expectation: they explain “hours clauses” and why multiple events may hit P&L more severely, leading to pricing discipline.
• GIFT City: they acknowledge it contributes to soft market via excess capacity and reinsurer capital availability, but sustainability depends on risk-adjusted returns.
• Evasive/partial/strong points:
• Strong: detailed CAT mechanics (“hours clauses”) and explicit discussion of renewal-cycle visibility.
• Evasive: they avoid certainty on duration of softness (“difficult to say with certainty”).

Theme D: IFRS/Ind AS transition—impact on profitability/ROE

• Core questions:
• Whether IFRS profitability could be materially higher given motor’s long-tail liabilities and deferred acquisition cost.
• Whether they are preparing and what ROE impact to expect.
• Management response:
• They have IRDAI one-year forbearance; implementation scheduled April 1, 2027.
• They are still assessing and won’t provide reliable estimates yet:
  • “We do not currently have a reliable estimate… would prefer to complete our assessment before providing any guidance.”
• Evasive/partial/strong points:
• Strong conservatism/credibility: refusal to quantify without assessment.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Motor OD loss ratio targets (Chola MS):
• “Immediate objective is to bring the OD loss ratio down… begins with a ‘7’, ideally in the high-70s”
• “aim… progressively move towards the mid-70s range over time”
• Timing signal: corrective measures “likely take a couple of quarters” to deliver meaningful results.

Implicit signals (qualitative)

• Pricing discipline improving in property insurance: expects “greater pricing discipline… over the coming quarters” after June NATCAT.
• Health: strategy is capability-building and profitability-first, with retail expansion requiring patience.
• Commercial lines: growth pursued “measured and disciplined”; not at expense of underwriting discipline.
• Judicial uncertainty remains: will monitor Supreme Court review petition outcome before provisioning decisions.
• IFRS impact: no numbers yet; “by next quarter… greater clarity” may allow preliminary observations.

5. Standout Statements (direct / revealing)

• Supreme Court provisioning stance (clear):
• “We have not taken any provision during the quarter in relation to the Supreme Court judgment.”
• OD loss ratio not acceptable + target setting (actionable):
• “We do not consider the current level of OD loss ratio to be acceptable.”
• “Immediate objective… begins with a ‘7’, ideally in the high-70s”
• “progressively move towards the mid-70s range over time”
• Time to results:
• “likely take a couple of quarters for these measures to deliver meaningful results”
• Health capability-building admission:
• “Health is one segment where we are essentially building capabilities from the ground up.”
• IFRS impact deferral (credibility-protecting):
• “We do not currently have a reliable estimate… would prefer to complete our assessment before providing any guidance”
• Reinsurance market softness explanation (mechanistic):
• “hours clauses… limits the ability of insurers to aggregate losses…”
• GIFT City uncertainty:
• “difficult to say with certainty” on duration of softness.

6. Red Flags / Positive Signals

Red flags
– Growth below expectations despite corrective measures: “While this growth was below our expectations…”
– OD loss ratio deterioration trend: management acknowledges it’s worsening and “not acceptable,” implying near-term earnings pressure.
– Judicial/regulatory uncertainty directly affects reserving decisions; they explicitly won’t provision yet.
– No quantified IFRS/ROE impact—could be a sign of complexity/uncertainty.

Positive signals
– Clear OD improvement roadmap with numeric targets and near-term timeframe.
– Operational KPIs in health:
– “99% of our health claims are settled within 30 days” and “NPS of 73”
– Solvency strength: solvency ratio “1.93 times” (comfortably above requirement).
– Prudent reserving posture acknowledged and defended with rationale (claims inflation assumptions).

7. Historical Comparison & Consistency Analysis (vs prior 3 calls)

a. Change in Tone Over Time

• Prior calls (Q2/Q3/Q4 FY26): management was already cautious, emphasizing motor OD/TP pressure and reserving prudence; they also gave more “directional” improvement expectations (e.g., OD improvement in coming quarters).
• Current call (Q1 FY27): tone is more execution- and target-driven on OD (explicit high-70s → mid-70s path), but still acknowledges underperformance and adds new uncertainty layers (Supreme Court review petition + IFRS assessment deferral).
• Classification shift: More Cautious on uncertainty, but more Optimistic on controllable actions (OD targets).

b. Tracking Past Commitments vs Outcomes

• Motor OD improvement expectation (Feb 2026 call):
• Past: “reduction of at least 3% to 5% over the next 2 quarters” (OD).
• Outcome in current call: OD loss ratio is described as further deteriorated to 80%+ in 1Q FY27.
• Flag: ❌ Missed / Delayed (at least directionally).
• ROE recovery ambition (Feb 2026 call):
• Past: aim to move back toward 16%–18% ROE over medium/long term.
• Current call: no ROE guidance; instead focuses on OD correction and IFRS assessment deferral.
• Flag: ⏳ Delayed / Not re-affirmed with numbers.
• IFRS transition preparation (Feb 2026 call):
• Past: discussion that IFRS could improve profitability due to discounting and DAC effects; some confidence expressed.
• Current call: still no reliable estimate, “premature” to comment.
• Flag: ⏳ Delayed (from guidance certainty standpoint).

c. Narrative Shifts

• Motor OD becomes even more central: earlier calls discussed OD/TP pressure broadly; now management is explicitly setting OD loss ratio numeric targets and calling it a “journey.”
• Health narrative evolves from “EOM/glide path” context to “capability-building + portfolio migration”: current call emphasizes product redesign, pricing revisions, migration from group platform to retail, and SME focus.
• New explicit judicial risk management: Supreme Court homemaker ruling is now directly addressed with a “no provision yet” stance.

d. Consistency & Credibility Signals

• Credibility improves where management is specific and conservative:
• Clear “no provision” stance on Supreme Court during the quarter.
• Refusal to quantify IFRS impact until assessment completed.
• Credibility concern: repeated expectations of OD improvement have not materialized directionally (OD still elevated and worsening).
• Overall credibility: Medium (good on conservatism/uncertainty disclosure; weaker on timing of OD improvement).

e. Evolution of Key Themes

• Demand/growth: growth constrained by pricing competition and volume softness; reinsurance accepted helps GWP but not direct GDPI.
• Margins/combined ratio: deterioration acknowledged; management focuses on underwriting/claims levers rather than blaming only macro.
• Expansion: health retail expansion framed as gradual and capability-dependent.
• Regulatory/accounting: IFRS/Ind AS/RBC/DPDP readiness is increasingly prominent, but financial impact remains uncertain.

f. Additional Insights (cross-period intelligence)

• The company’s “corrective measures” language is consistent, but the OD loss ratio trajectory suggests either:
• measures take longer than previously implied, or
• underlying claims inflation/settlement dynamics are outpacing underwriting actions.
• The shift to explicit OD numeric targets may indicate management recognizes prior guidance/timing may not have been sufficient, and is trying to regain control through measurable milestones.
• Judicial uncertainty is being handled with wait-and-see reserving—this can protect near-term earnings but increases future volatility risk.